Direct oral anticoagulants (DOACs).
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
University Healthcare Thrombosis Service, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Sara
S
Vazquez
Division of General Internal Medicine, Department of Internal Medicine, Salt Lake City, UT, USA Molecular Medicine Program, University of Utah School of Medicine, Salt Lake City, UT, USA Department of Internal Medicine, George E. Wahlen Salt Lake City VAMC, Salt Lake City, UT, USA matthew.rondina@hsc.utah.edu.
Matthew T
MT
Rondina
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D000991:Antithrombins / Q000008:administration & dosage; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran / Q000008:administration & dosage; D016527:Drug Costs; D016903:Drug Monitoring / Q000379:methods; D065427:Factor Xa Inhibitors / Q000008:administration & dosage; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D019934:International Normalized Ratio; D018579:Patient Selection; D011720:Pyrazoles / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage; D011728:Pyridones / Q000008:administration & dosage; D012307:Risk Factors; D000069552:Rivaroxaban / Q000008:administration & dosage; D013844:Thiazoles / Q000008:administration & dosage
D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013844:Thiazoles; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran; C552171:edoxaban
DVT; anticoagulants; apixaban; dabigatran; edoxaban; pulmonary embolism; rivaroxaban; thrombosis